InvestorsHub Logo
Replies to #97506 on Biotech Values
icon url

genisi

06/20/10 5:18 AM

#97508 RE: DewDiligence #97506

Agree that waiting for the results of the ARISTOTLE trial before submitting an NDA for Apixaban in AF/stroke prevention is the more likely scenario.